Marketing

• Map the current IBD (UC and CD) patient care pathway to include identifying gaps and opportunities to create a best-in-class patient experience in support of launching tulisokibart in IBD
• Develop strategic priorities for engagement of IBD patient associations to include alignment with Global Pharmaceuticals policy and Global Medical and Scientific affairs in support of IBD launch
• Identify key elements of a patient support program to address these gaps in consideration of competitive external offerings in the U.S. and key early launch ex-U.S. markets
• Develop and articulate the global Therapy Patient Program strategy and framework to guide countries in the creation of compliant, patient-centered support initiatives.
• Define global standards, KPIs, and best practices for TPP/PSP implementation and measurement.
• Create modular, adaptable program elements that local teams can customize for their markets.
• Partner with cross-functional global teams (medical, market access, commercial, digital, compliance, legal, pharmacovigilance, policy) to ensure programs are scientifically sound, ethical, compliant, implementable, and align with cross-functional strategies.

Director, Global Marketing – Immunology Patient Strategy

Senior Director, Marketing Modernization

Director, Marketing Excellence

Director, Marketing Excellence

Director, Regional Marketing – US Ophthalmology

Associate Director, Marketing Sciences